|
SUMMARY OF SIGNIFICANT ACCOUNTING PRINICPLES (Detail Textual 4) (USD $)
|
1 Months Ended | 3 Months Ended | 6 Months Ended | 88 Months Ended | ||||
|---|---|---|---|---|---|---|---|---|
|
Mar. 18, 2014
|
Sep. 18, 2008
|
Jun. 30, 2014
|
Jun. 30, 2013
|
Jun. 30, 2014
|
Jun. 30, 2013
|
Jun. 30, 2014
|
Jul. 01, 2014
Subsequent Event [Member]
|
|
| Schedule Of Significant Accounting Principles [Line Items] | ||||||||
| Cumulative deferred tax assets | $ 7,200,000 | $ 7,200,000 | $ 7,200,000 | |||||
| Net operating losses available for 2030 | 3,600,000 | 3,600,000 | 3,600,000 | |||||
| Net operating losses available for 2031 | 6,700,000 | 6,700,000 | 6,700,000 | |||||
| Net operating losses available for 2032 | 3,900,000 | 3,900,000 | 3,900,000 | |||||
| Net operating losses available for 2033 | 4,700,000 | 4,700,000 | 4,700,000 | |||||
| Net operating losses available for 2034 | 2,400,000 | 2,400,000 | 2,400,000 | |||||
| Expected volatility rate of stock | 50.00% | 50.00% | 50.00% | |||||
| Research and development | 899,662 | 994,706 | 1,469,017 | 1,723,211 | 14,469,607 | |||
| Number of shares issued | 30,000,000 | 200,000 | ||||||
| Common stock purchase warrants | 15,000,000 | |||||||
| Value of shares issued | $ 3,000,000 | $ 50,000 | ||||||
| Stock options compensation | 10,000,000 | |||||||
| X | ||||||||||
|
- Definition
This element represents expected volatility rate of stock estimated by management. No definition available.
|
| X | ||||||||||
|
- Definition
This element represents Net operating losses available for carryover to be used against taxable income generated through future period. No definition available.
|
| X | ||||||||||
|
- Definition
This element represents net operating losses available for carryover to be used against taxable income generated through future period one. No definition available.
|
| X | ||||||||||
|
- Definition
This element represents net operating losses available for carryover to be used against taxable income generated through future period one. No definition available.
|
| X | ||||||||||
|
- Definition
This element represents Net operating losses available for carryover to be used against taxable income generated through future period one. No definition available.
|
| X | ||||||||||
|
- Definition
This element represents Net operating losses available for carryover to be used against taxable income generated through future period one. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Number of new stock issued during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|